Overview

A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors.

Status:
Active, not recruiting
Trial end date:
2022-03-26
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of RO7296682 in participants with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Hoffmann-La Roche